Erratum to Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK (Infection, 10.1007/s15010-014-0641-1);Oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK

Infection

Volumn 42, Issue 5, 2014, Pages 843-847

  Saeed, K ^a   Ahmad, N ^b   Dryden, M ^a,c   Cortes, N ^d   Marsh, P ^b   Sitjar, A ^a   Wyllie, S ^d   Bourne, S ^e   Hemming, J ^f   Jeppesen, C ^g   Green, S ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^e POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^g DORSET COUNTY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

mecA; mecC; Methicillin; MRSA; OS MRSA; PVL

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; MECA PROTEIN, STAPHYLOCOCCUS AUREUS; METICILLIN; OXACILLIN; PANTON-VALENTINE LEUKOCIDIN;

CLINICAL TRIAL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCAL INFECTIONS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENGLAND; EXOTOXINS; HUMANS; LEUKOCIDINS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXACILLIN; PREVALENCE; STAPHYLOCOCCAL INFECTIONS;

EID: 84918774340     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0663-8     Document Type: Erratum

References (35)

1. Tomassz A, Nachman S, Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother. 1991;35:124–9.
2. Rohrer S, Maki H, Berger-Bächi B. What makes resistance to methicillin heterogeneous? J Med Microbiol. 2003;52:605–7.
3. Saeed K, Marsh P, Ahmad N. Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection? Curr Opin Infect Dis. 2014;27:130–6.
4. Saeed K, Dryden M, Parnaby R. Oxacillin-susceptible MRSA, the emerging MRSA clone in the UK? J Hosp Infect. 2010;76:267–8.
5. Saeed K, Green S, Ahmed N, Dryden M. oxacillin-susceptible methicillin-resistant Staphylococcusaureus: an emerging threat for UK hospitals? Poster presentation No 16 at the Health Protection Agency annual Conference, Warwick/UK. September 2011. https://www.hpa-events.org.uk/hpa/frontend/reg/absViewDocumentFE.csp?popup=1&documentID=4047&eventID=127. Accessed 01 April 2014.
6. Cuirolo A, Canigia LF, Gardella N, et al. Oxacillin- and cefoxitin-susceptible methicillin-resistant Staphylococcus. Int J Antimicrob Agents. 2011;37:178–9.
7. Kumar VA, Steffy K, Chatterjee M, et al. Detection of oxacillin-susceptible mecA-positive Staphylococcus aureus isolates using chromogenic medium MRSA ID. J Clin Microbiol. 2013;51:318–9.
8. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997;10:781–91.
9. Hososaka Y, Hanaki H, Endo H, et al. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother. 2007;13:79–86.
10. He W, Chen H, Zhao C, Zhang F, Wang H. Prevalence and molecular typing of oxacillin-susceptible mecA-positive Staphylococcus aureus from multiple hospitals in China. Diagn Microbiol Infect Dis. 2013;77:267–9.
11. Edward JP, Cartwrighta BC, Gavin K, et al. Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2013;51:2732–4.
12. García-Garrote F, Cercenado E, Marín M, et al. Methicillin-resistant Staphylococcus aureus carrying the mecC gene: emergence in Spain and report of a fatal case of bacteraemia. J Antimicrob Chemother. 2014;69:45–50.
13. Cuny C, Layer F, Strommenger B, Witte W. Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PLoS One. 2011;6:e24360.
14. Ito T, Hiramatsu K, Tomasz A, et al. Guidelines for reporting novel mecA gene homologues. Antimicrob Agents Chemother. 2012;56:4997–9.
15. García-Álvarez L, Holden MTG, Lindsay H, et al. Methicillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11:595–603.
16. Public Health England, UK Standards for Microbiology Investigations. http://www.hpa.org.uk/ProductsServices/MicrobiologyPathology/UKStandardsForMicrobiologyInvestigations/TermsOfUseForSMIs/AccessToUKSMIs/. Accessed on 31 Jan 2014.
17. BSAC methods for antimicrobial susceptibility testing version 11.1 May 2012. http://www.bsac.org.uk. Accessed on 31 Jan 2014.
18. McDonald RR, Antonishyn NA, Hansen T, et al. Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005;43:6147–9.
19. Lina G, Pie´mont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–32.
20. Bruno Pichon, Robert Hill, Frederic Laurent, et al. Development of a real-time quadruplex PCR assay for simultaneous detection of nuc, Panton–Valentine leucocidin (PVL), mecA and homologue mecALGA251. J Antimicrob Chemother 2012; 67: 2338–2341 doi:10.1093/jac/dks221. Accessed 11 June 2012.
21. Murchan S, Kaufmann ME, Deplano A, et al. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol. 2003;41:1574–85.
22. Paterson GK, Larsen AR, Robb A, et al. The newly described mecA homologue, mecA(LGA251), is present in methicillin-resistant Staphylococcus aureus isolates from a diverse range of host species. J Antimicrob Chemother. 2012;67:2809–13.
23. Shore AC, Deasy EC, Slickers P, et al. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55:3765–73.
24. Laurent F, Chardon H, Haenni M, et al. MRSA harboring mecA variant gene mecC, France. Emerg Infect Dis. 2012;18:1465–7.
25. Hellman J, Olsson-Liljequist B. A report on Swedish antibiotic utilisation and resistance in human medicine. Swedish Institute for Communicable Disease Control, Solna, Sweden. 2012. www.smi.se/publikationer or www.sva.se. Accessed 12 Oct 2013.
26. Schaumburg F, Köck R, Mellmann A, et al. Population dynamics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J Clin Microbiol. 2012;50:3186–92.
27. Basset P, Prod’hom G, Senn L, et al. Very low prevalence of methicillin-resistant Staphylococcus aureus carrying the mecC gene in western Switzerland. J Hosp Infect. 2013;83:257–9.
28. Medhus A, Slettemeas JS, Marstein L, et al. Methicillin-resistant Staphylococcus aureus with the novel mecC gene variant isolated from a cat suffering from chronic conjunctivitis. J Antimicrob Chemother. 2013;68:968–9.
29. Paterson GK, Morgan FJ, Harrison EM, et al. Prevalence and characterization of human mecC methicillin-resistant Staphylococcus aureus isolates in England. J Antimicrob Chemother. 2014;69:907–10.
30. Holmes A, Ganner M, McGuane S, et al. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43:2384–90.
31. Pu W, Su Y, Li J, Li C, Yang Z, et al. High Incidence of oxacillin-susceptible mecA-Positive Staphylococcus aureus (OS-MRSA) Associated with Bovine Mastitis in China. PLoS One. 2014;9:e88134. doi:10.1371/journal.pone.0088134.
32. Giannouli S, Labrou M, Kyritsis A, et al. Detection of mutations in the FemXAB protein family in oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates. J Antimicrob Chemother. 2010;65:626–33.
33. Ikonomidis A, Michail G, Vasdeki A, et al. In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcusaureus. Antimicrob Agents Chemother. 2008;52:3905–8.
34. Labrou M, Michail G, Ntokou E, et al. Activity of οxacillin versus vancomycin against oxacillin-susceptible mecA-Positive Staphylococcus aureus clinical isolates by population analyses, time-kill assays and a murine thigh infection model. Antimicrob Agents Chemother. 2012;56:3388–91.
35. Sakoulas G, Gold HS, Venkataraman L, et al. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol. 2001;39:3946–51.